Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California
blank

 

Recent News and Articles on the Keywords: july 30 + news release + arthritis  Related to the article below (Last Update: 5/5/2008)

QualityStocks.net "Top Movers and Shakers" for 4/30/2008
TransWorldNews (press release), GA - Apr 30, 2008
On July 12, 2007, CalStar Oil & Gas Limited and Nomad Hydrocarbons LLC, (the Company owns 80% of Nomad Hydrocarbons LLC, through its wholly owned ...
Biogen Idec Reports First Quarter 2008 Results
FOXBusiness - Apr 23, 2008
According to data available as of the end of March 2008: -- There have been no cases of PML since re-launch in the US and launch internationally in July ...BIIB
Amgen 1st-Quarter Net Rises 2% on Enbrel Sales Growth (Update2)
Bloomberg - Apr 24, 2008
Enbrel, a treatment for rheumatoid arthritis and psoriasis, generated $951 million in revenue in the first quarter, a 30 percent increase from a year ...AMGN
Interim Report on Biotie Therapies Corp. January 1 - March 31, 2008
FOXBusiness - Apr 25, 2008
Pathological accumulation of white blood cells in tissue is a common feature in many autoimmune diseases, such as rheumatoid arthritis, ulcerative colitis, ...PINK:BORPF - SOMX
Theralase Reports 2007 Fourth Quarter and Year-End Results
Canada NewsWire (press release), Canada - Apr 30, 2008
TLC-3000: Cancer Therapy and Wound Healing On July 1, 2007, Theralase, in conjunction with the University Health Network (UHN) and the Ontario Centres of ...CVE:TLT
Biogen Idec and Elan Present New TYSABRI(R) Data at the 60th ...
FOXBusiness - Apr 16, 2008
There have been no cases of PML since re-launch in the US and launch internationally in July 2006. -- Of those patients, over 9900 have received at least ...BIIB - ELN
Amgen's First Quarter 2008 Adjusted Earnings Per Share Increased 4 ...
Genetic Engineering News (press release), NY - Apr 24, 2008
AMG 108: The Company discussed results from its recently completed Phase 2 study in Rheumatoid Arthritis (RA). AMG 108 appeared to be well tolerated and ...AMGN
Foundation chooses president
Akron Beacon Journal, OH - Apr 8, 2008
Petures, with nearly a 30-year career in nonprofits, will replace Jody Bacon, who plans to retire in July from the philanthropic endowment. ...
INSIDE INDIANA BUSINESS column: Delphi investment deal falls through
nwitimes.com, IN - Apr 5, 2008
The decision will eliminate more than 60 jobs in Angola starting in July. Officials from the Toyota plant in Princeton have reaffirmed their commitment to ...OTC:DPHIQ
Hits and Misses: Tuesday's Earnings Reports
FOXBusiness - Apr 22, 2008
To help improve margins, he said the company is exiting its Northwest region as of July 1. Media and marketing company Meredith Corp. ...YHOO
Source: Google News

… tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by … -
A Luttun, M Tjwa, L Moons, Y Wu, A Angelillo- … - Nature Medicine, 2002 - nature.com
... 8, 831 - 840 (2002) Published online: 1 July 2002; | doi ... of new vessels given that
25-30% of the ... PlGF and VEGF might affect SMCs indirectly via release of SMC ...

Leukocyte-endothelial interactions: Clinical trials of anti-adhesion therapy. -
JM Harlan, RK Winn - Critical Care Medicine, 2002 - ccmjournal.com
... 30. ... Fikes BJ: A deep bench pays off. Available at: http://www.doubletwist.com/
news/columns/article.jhtml . ... Stroke. 34(7):1777-1782, July 2003. ...

[PDF] Lumiracoxib (Novartis) -
C Ding, G Jones - IDrugs, 2002 - eprints.utas.edu.au
... AG BANK VONTOBEL 2000 July 392075 Pharmaceuticals ... Novartis AG COMPANY PRESENTATION
2001 October 30 ... Novartis Pharmaceuticals Corp PRESS RELEASE 2002 May 21 ...

-
JM Dunn - US Patent 4,375,468, 1983 - Google Patents
... No. 06/282,544, filed July 13, 1981 now abandoned. BACKGROUND OF THE INVENTION 5 ...
15 20 25 30 35 40 ... lubricant, and tabletted on a rotary press. A tablet with ...

The media battle between Celebrex and Vioxx: influencing media coverage but not content -
WB Anderson - Public Relations Review, 2001 - Elsevier
... on the market (January -July 1999), Celebrex ... its launch, Celebrex generated 30 million
prescriptions ... medications.?[22] The Merck news release announcing FDA ...

Successful use of autologous bone marrow transplantation in treating a patient with POEMS syndrome -
M Soubrier, M Ruivard, JJ Dubost, B Sauvezie, P … - Bone Marrow Transplantation, 2002 - nature.com
... Arthritis Rheum 1997; 40: 786-787. MEDLINE. 5 Nakano A, Mitsui T, Endo I et
al. ... MEDLINE. July (1) 2002, Volume 30, Number 1, Pages 61-62. ...

[PDF] Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome -
C Ding - Curr Opin Investig Drugs, 2006 - eprints.utas.edu.au
... In July 2006, Vertex was planning to file an IND in ... Vertex Pharmaceuticals Inc PRESS
RELEASE 2005 June 10 608092 p38 ... DISCOV DEVEL 2005 8 4 421-30 649069 Vertex ...
-

… bold gamma receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese … -
C Kyogoku, N Tsuchiya, K Matsuta, K Tokunaga - Genes and Immunity, 2002 - nature.com
... Arthritis Rheum 1987; 30: 1205-1213. ... EJ (eds) Prehistoric Mongoloid Dispersals Oxford
University Press: Oxford, 1996 ... 14 May 2002; revised 8 July 2002; accepted ...

Prevention of Arthritis by Interleukin 10-producing B Cells -
C Mauri, D Gray, N Mushtaq, M Londei - Journal of Experimental Medicine, 2003 - Rockefeller Univ Press
... Rockefeller University Press, 0022-1007 ... the proinflammatory Th1 type response via
the release of IL ... Submitted: July 30, 2002 Revised: December 10, 2002 Accepted ...

FDA Approvals: Expanded Indications for Lipitor, Humira, and Hyzaar
Y Waknine - medscape.com
... On July 30, the FDA approved an expanded indication ... to severely active rheumatoid
arthritis (RA) who ... 2. According to the company news release, this decreases ...

Source: Google Scholar

Inflammatory Joint, Bowel Diseases May Be Linked

Ankylosing spondylitis, inflammatory bowel disorder share common genetics, study suggests

(SOURCE: Arthritis & Rheumatism, news release, July 30, 2007)

MONDAY, July 30 (HealthDay News) -- People whose blood relatives have the joint disease ankylosing spondylitis (AS) are at increased risk not just for AS, but for inflammatory bowel disease (IBD) as well, an Icelandic study shows.

Looking at data from six generations of Icelanders, the researchers discovered a familial link between IBD and AS, an inflammatory disease that primarily affects the spine.

People with AS often suffer from chronic bowel disease and gastrointestinal distress, and both AS and IBD are known to run in families. However, prior to this study, no link had been identified between the two conditions.

According to the researchers, Icelanders provide an ideal study population, because the environmental and lifestyle factors are the same throughout the country. Iceland also maintains an extensive genealogical registry, as well as a half century of records on both AS and IBD sufferers, providing a mine of data for researchers.

Researchers at Landspitali University Hospital, Reykjavik, analyzed the databases for the occurrence of IBD and AS among relatives and the risk of inheriting either and both disorders.

Health information from more than 200 people with AS and more than 1,350 people diagnosed with IBD, as well as genealogic data from more than 790,000 Icelanders, revealed extensive clustering of AS and IBD in families.

First-, second- and third-degree relatives of people with either disorder had increased risks of developing the same disorder, with the risk decreasing as people moved further out on the family tree. First-degree relatives are immediate blood relatives; second-degree relatives are aunts, uncles, nieces, nephews and grandparents; and third-degree relatives are those who share one-eighth of the genetic code, such as first cousins.

The researchers write in the August issue of Arthritis & Rheumatism that the key finding was the increased cross-risk for close relatives of AS and IBD sufferers. In other words, blood relatives of an IBD sufferer also had a greater risk of having AS, and blood relatives of an AS sufferer were at greater risk of IBD. This is the first study to demonstrate a possible hereditary pattern between the two conditions, wrote the researchers, although the specific genetic mechanism has yet to be identified.

"Our results provide strong evidence that a molecular-genetic approach should be utilized in patients with these diseases," the study's lead author, Dr. Bjarni Thjodleifsson, said in a prepared statement. "If this approach proves successful, this will open the possibility of identifying a common early pathophysiologic event in both AS and IBD that may be amenable to new and selective treatments."

The Spondylitis Association of America estimates that there are at least 500,000 people in the United States with AS, although many cases go undiagnosed. Inflammatory bowel disease is thought to affect up to 600,000 people every year.

More information

To learn more about ankylosing spondylitis, visit the Spondylitis Association of America
 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.